Acciones Pressure BioSciences, Inc. Other OTC
Acciones
PBIO
US74112E2081
Equipo médico, suministros y distribución
Ventas 2021 | 2 M 1,85 M | Ventas 2022 | 1,73 M 1,6 M | Capitalización | 15,89 M 14,69 M |
---|---|---|---|---|---|
Resultado Neto 2021 | -20 M -18,49 M | Resultado Neto 2022 | -16 M -14,79 M | VE / Ventas 2021 | 16,4 x |
Deuda neta 2021 | 14,51 M 13,41 M | Deuda neta 2022 | 20,53 M 18,98 M | VE / Ventas 2022 | 21,1 x |
P/E ratio 2021 |
-0,68
x | P/E ratio 2022 |
-0,81
x | Empleados | - |
Rendimiento 2021 * |
-
| Rendimiento 2022 |
-
| Flotante | 98,82 % |
Último transcript sobre Pressure BioSciences, Inc.
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 73 | 01/08/78 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 24/04/06 |
Chief Tech/Sci/R&D Officer | 59 | 03/04/06 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 73 | 01/08/78 | |
Vito Mangiardi
BRD | Director/Board Member | 75 | 03/07/12 |
Michael Urdea
BRD | Director/Board Member | 71 | 08/02/13 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,82 % | 182 mil M | |
+2,51 % | 111 mil M | |
-2,15 % | 68,48 mil M | |
+1,27 % | 49,69 mil M | |
+8,18 % | 44,46 mil M | |
+2,33 % | 40,67 mil M | |
+21,85 % | 31,22 mil M | |
+2,17 % | 26,09 mil M | |
+15,30 % | 25,32 mil M |